Core Viewpoint - A class action securities lawsuit has been filed against Lantheus Holdings, Inc. for alleged securities fraud affecting investors between February 26, 2025, and August 5, 2025 [1][2] Group 1: Lawsuit Details - The lawsuit claims that Lantheus made false statements and concealed information regarding its revenue outlook and growth potential, particularly related to the sales growth of its product Pylarify [2] - Allegations include that Lantheus misrepresented its understanding of market dynamics, including competition, pricing, seasonality, and macroeconomic factors [2] Group 2: Investor Information - Investors who suffered losses during the specified period have until November 10, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky has a history of securing significant settlements for shareholders and is recognized as one of the top securities litigation firms in the United States [4]

Core Viewpoint - Investors in Lantheus Holdings, Inc. have the opportunity to lead a securities fraud class action lawsuit due to alleged misleading statements regarding the company's market understanding and business prospects [1][2]. Summary by Relevant Sections Lawsuit Details - The lawsuit claims that from February 26, 2025, to August 5, 2025, Lantheus failed to disclose critical information about its understanding of the pricing and competitive dynamics of the Pylarify market [2]. - The complaint asserts that the positive statements made by the defendants regarding the company's business operations and future prospects were materially misleading and lacked a reasonable basis [2]. Participation Information - Investors who suffered losses on their Lantheus investments are encouraged to participate in the lawsuit, with a lead plaintiff deadline set for November 10, 2025 [2]. - Interested parties can contact Glancy Prongay & Murray LLP for more information or to learn about their rights regarding the lawsuit [3][4].

Core Viewpoint - A class action securities lawsuit has been filed against Lantheus Holdings, Inc. for alleged securities fraud affecting investors between February 26, 2025, and August 5, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that the defendants made false statements and concealed information regarding the company's revenue outlook and growth potential, particularly related to Pylarify's sales growth and market dynamics [2]. - It is alleged that Lantheus did not accurately understand the pricing and competitive dynamics of Pylarify's market, contrary to the optimistic reports provided by the company [2]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until November 10, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, indicating no financial obligation to participate in the lawsuit [3]. Group 3: Law Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4].

Core Viewpoint - A class action lawsuit has been filed against Lantheus Holdings, Inc. for allegedly making false and misleading statements regarding its market position and product performance, particularly concerning Pylarify [2]. Group 1: Lawsuit Details - The class period for the lawsuit is from February 26, 2025, to August 5, 2025, with a deadline for lead plaintiff appointments set for November 10, 2025 [2]. - The complaint alleges that Lantheus overstated the market leadership of Pylarify while its competitors were gaining market share, leading to significant declines in sales throughout 2025 [2]. Group 2: Shareholder Participation - Shareholders who purchased shares during the class period are encouraged to contact the DJS Law Group for potential lead plaintiff appointments, although this is not required to participate in any recovery [2][3]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive updates on the case status at no cost [3]. Group 3: Law Firm Background - DJS Law Group specializes in securities class actions and corporate governance litigation, focusing on enhancing investor returns through advocacy [4].

Core Viewpoint - A class action lawsuit has been filed against Lantheus Holdings, Inc. for allegedly making materially false and misleading statements regarding its product Pylarify and its competitive position during the specified class period [7]. Allegation Details - The lawsuit claims that Lantheus provided overly positive statements while concealing adverse facts about Pylarify's competitive position [3]. - It is alleged that Lantheus was not adequately equipped to assess pricing and competitive dynamics for Pylarify [3]. - The company reportedly failed to disclose that a price increase in early 2025, despite previous price erosion, created opportunities for competitive pricing, jeopardizing Pylarify's price point and growth potential [3]. - As a result, statements made by the defendants regarding the company's business and prospects were materially false and misleading [3]. Next Steps - Investors who purchased Lantheus shares and suffered losses are encouraged to contact the law firm for more information and to discuss their rights [4]. - There is no cost or obligation for investors to inquire about their claims [4]. - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is November 10, 2025 [7].

Core Viewpoint - A securities class action lawsuit has been filed against Lantheus Holdings, Inc. for allegedly making false and misleading statements regarding its product PYLARIFY and its competitive position during the specified Class Period from February 26, 2025, to August 5, 2025 [1][2]. Group 1: Allegations Against Lantheus - The lawsuit claims that Lantheus misled investors about the competitive position of PYLARIFY, failing to properly assess pricing and competitive dynamics [2]. - It is alleged that Lantheus did not disclose that a price increase in early 2025, despite previous price erosion, created opportunities for competitive pricing, jeopardizing PYLARIFY's revenue and growth potential [2]. - The complaint asserts that the public statements made by Lantheus were materially false and misleading throughout the Class Period [2]. Group 2: Legal Process and Participation - Investors in Lantheus have until November 10, 2025, to seek appointment as lead plaintiff, representing the class in the litigation [3]. - A lead plaintiff is typically the investor or group of investors with the largest financial interest and who are representative of the class [3]. - Participation as a lead plaintiff does not affect an investor's ability to share in any recovery from the lawsuit [3]. Group 3: Firm Background - Kessler Topaz Meltzer & Check, LLP is known for prosecuting class actions and has a reputation for recovering billions for victims of corporate misconduct [4]. - The firm aims to protect investors and consumers from fraud and negligence by businesses [4].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Lantheus Holdings, Inc. due to misleading statements regarding the competitive position of its product Pylarify, which led to significant financial losses for investors [4][6]. Group 1: Legal Investigation - Faruqi & Faruqi is encouraging investors who suffered losses in Lantheus between February 26, 2025, and August 5, 2025, to discuss their legal options [1]. - There is a deadline of November 10, 2025, for investors to seek the role of lead plaintiff in a federal securities class action against Lantheus [4]. Group 2: Financial Performance and Impact - Lantheus reported disappointing first-quarter results on May 7, 2025, with Pylarify's performance falling short of market expectations [7]. - On August 6, 2025, Lantheus announced further disappointing results, with Pylarify's revenue declining by 8.3% year-over-year and a significant reduction in fiscal year 2025 growth projections [7]. - Following these announcements, Lantheus' stock price plummeted from $72.83 per share on August 5, 2025, to $51.87 per share on August 6, 2025, marking a decline of approximately 28.8% in one day [8]. Group 3: Class Action Details - The lead plaintiff in a class action is defined as the investor with the largest financial interest who can adequately represent the class [9]. - Any member of the class can move the court to serve as lead plaintiff or choose to remain an absent class member without affecting their ability to share in any recovery [9]. Group 4: Call for Information - Faruqi & Faruqi is also seeking information from whistleblowers, former employees, and shareholders regarding Lantheus' conduct [10].

Core Viewpoint - The Gross Law Firm is notifying shareholders of Lantheus Holdings, Inc. about a class action lawsuit due to alleged false statements regarding the company's revenue outlook and market dynamics [1][3]. Group 1: Allegations - The complaint alleges that Lantheus Holdings made false statements and concealed information about its projected revenue and growth, creating a misleading impression of its market position [3]. - Specifically, the company reportedly overstated the sales growth potential of its product Pylarify and downplayed risks related to competition, pricing, seasonality, and macroeconomic factors [3]. Group 2: Class Action Details - The class period for the lawsuit is from February 26, 2025, to August 5, 2025, and shareholders are encouraged to register for participation by the deadline of November 10, 2025 [3][4]. - Shareholders who register will receive updates on the case's progress and can seek to be appointed as lead plaintiff, although this is not a requirement for recovery [4]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies engage in responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions [5].

Core Viewpoint - The Lantheus Holdings, Inc. class action lawsuit alleges that the company and its executives misled investors regarding the company's revenue outlook and growth potential, particularly concerning its key product, Pylarify, which is used in prostate cancer diagnosis and treatment [3][4][5]. Company Overview - Lantheus develops, manufactures, and commercializes diagnostic and therapeutic products for heart, cancer, and other diseases globally, with Pylarify being a significant product in its portfolio [2]. Allegations of Misrepresentation - The lawsuit claims that Lantheus's executives created a false impression of the company's revenue projections and growth while downplaying risks from competition and market dynamics [3]. - It is alleged that Lantheus's optimistic sales growth reports for Pylarify did not align with actual market conditions, leading to a lack of accurate understanding of pricing and competitive dynamics [3]. Financial Performance and Stock Impact - On May 7, 2025, Lantheus reported a year-over-year decrease in Pylarify sales, attributing it to a "temporal competitive disruption," and subsequently lowered its full-year growth projections from low-single-digit to mid-single-digit growth to flat-to-low single-digit growth [4]. - Following this announcement, Lantheus's stock price fell by more than 23% [4]. - On August 6, 2025, the company announced further disappointing results, with Pylarify sales down 8.3% year-over-year, leading to a nearly 29% drop in stock price after slashing fiscal year 2025 growth projections [5]. Legal Process for Lead Plaintiff - The Private Securities Litigation Reform Act of 1995 allows investors who purchased Lantheus securities during the class period to seek appointment as lead plaintiff in the lawsuit, representing the interests of all class members [6].

Do you, or did you, own shares of Lantheus Holdings, Inc. (NASDAQ: LNTH)?Did you purchase your shares between February 26, 2025 and August 5, 2025, inclusive?Did you lose money in your investment in Lantheus Holdings, Inc.?Do you want to discuss your rights? NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH) investors of an upcoming deadline involving a securities f ...